Cabinet Regulation No. 401 of 2004 on Procedures for Monitoring of Adverse Reactions Caused by Veterinary Medicinal Products

Sujet

Bétail

Mot clé

Santé des animaux Médicaments Questions de procédures Aliments pour animaux Emballage/étiquetage Normes environnementales Protection de l’environnement Normes

Aire géographique

Europe, Europe et Asie Centrale, Pays de l'Union Européenne, Europe du Nord

Résumé

These Regulations prescribe the procedures by which the monitoring of possible adverse reactions caused by veterinary medicinal products shall be performed. These Regulations apply to the adverse reactions caused to animals - by the use of veterinary medicinal products (also medical treatment pre-mixture added to medicated feed); by the medicinal products, which are intended for humans, used in veterinary medicine; and by the use of veterinary medicinal products in a manner incompatible with the information indicated on a labelling and package leaflet; humans - by the incidental use of veterinary medicinal products or their use for animals; possible - by the veterinary medicinal products getting into the environment (pollution); by the inefficiency of veterinary medicinal products; and by the changes during withdrawal period of the veterinary medicinal products from the organism.

Texte intégral

Letton/Anglais

Site web

likumi.lv

Références - Législation

Implemente

Directive 2001/82/EC of the European Parliament and of the Council on the Community code relating to veterinary medicinal products.

Législation | Union européenne | 2001

Mot clé: Législation de base, Santé des animaux, Médicaments, Autorisation/permis, Collecte de données/déclarations, Accès-à-l'information, Inspection, Commerce intérieur, Commerce international, Infractions/sanctions

Source: FAO, FAOLEX